High Evidence
Research Overview
SS-31 Research for Age-Related Macular Degeneration
An evidence-based overview of research examining SS-31 in the context of age-related macular degeneration. This page synthesizes findings from peer-reviewed literature.
Research Summary
ReCLAIM Phase 2 showed statistically significant improvement in low-luminance visual acuity in dry AMD patients. ReCLAIM-2 Phase 2b trial evaluating effect on geographic atrophy progression is ongoing with results expected 2026.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. SS-31 may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.